Table 2. Gravimetric and echocardiographic data of PTX3-TG mice after TAC.
Sham | TAC 4 weeks | |
Gravimetric data | ||
BW (g) | ||
WT | 27.2±1.7 | 25.3±3.8* |
PTX3-TG | 28.0±1.8 | 24.2±2.5* |
HW to BW ratio (mg/g) | ||
WT | 5.10±0.22 | 6.78±0.76** |
PTX3-TG | 5.07±0.31 | 8.03±1.68** # |
LW to BW ratio (mg/g) | ||
WT | 5.21±0.61 | 6.22±0.73* |
PTX3-TG | 5.21±0.49 | 9.28±3.17** # |
Echocardiographic data | ||
Heart rate (beats/min) | ||
WT | 501±21.2 | 486±33.7 |
PTX3-TG | 509±19.4 | 483±47.3 |
IVS (mm) | ||
WT | 0.67±0.05 | 1.00±0.18** |
PTX3-TG | 0.67±0.07 | 0.72±0.14## |
LVEDD (mm) | ||
WT | 2.88±0.20 | 2.82±0.25 |
PTX3-TG | 2.96±0.14 | 3.54±0.31## |
LVFS (%) | ||
WT | 51.6±4.3 | 44.6±3.8** |
PTX3-TG | 51.7±4.6 | 35.5±2.7** ## |
Abbreviations as in Table 1. PTX3-TG, PTX3 cardiac-specific overexpression mice. All data are shown as mean ± SD (n = 10 per group,).
P<0.05 and
P<0.01 vs. sham mice of the same strain;
P<0.05 and
P<0.01 vs. TAC-operated WT mice at each time point, respectively.